Era7 Bioinformatics
Private Company
Funding information not available
Overview
Era7 Bioinformatics is a private, research-driven company offering specialized bioinformatics services focused on bacterial genomics and metagenomics. Its core business model is providing analytical services and tailored software, positioning it in the 'Services' and 'Platform' categories. While the company has established a portfolio of proprietary analysis tools like BG7 and MG7, its website content appears compromised with unrelated spam, indicating potential operational or reputational risks. The company is likely in an 'Early Revenue' stage, serving research and commercial clients in the genomics sector.
Technology Platform
Suite of proprietary bioinformatics pipelines for bacterial genomics (BG7 for annotation, CG7 for comparative genomics, AG7 for genome closing, MG7 for metagenomics) and RNA-seq analysis, delivered via cloud computing and open-source frameworks.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Era7 competes in a crowded bioinformatics services market against large CROs, sequencing platform companies offering integrated analysis suites, academic core facilities, and numerous other specialized startups. Its differentiation is its specific focus on bacterial genomics, but maintaining a technological edge is challenging.